InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Steele Glenn Jr Md Phd. Insider active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 5 disclosures have been published. History available since 7 January 2022. The latest transaction was disclosed on 2 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Steele Glenn Jr Md Phd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
12,000 shares@ US$30.86100.0% of flowCommon StockSEC:0001269131-26-000003:0
4,000 shares0Common StockSEC:0001415889-25-001028:0
4,000 shares0Common StockSEC:0001415889-24-004099:0
4,000 shares0Common StockSEC:0001415889-23-000670:0
3,200 shares0Common StockSEC:0001179110-22-000383:0
5 of 5 declarations
About Steele Glenn Jr Md Phd
STEELE GLENN JR MD PHD is a declarant and, according to the provided records, a Director of PTC Therapeutics, INC. The total number of filings is 5, and the recent filings observed run from 2022-01-11 to 2025-01-07, with buy and sell amounts shown as EUR 0 in the sampled filings, and the modal transaction nature being Attribution.
